To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06408688
Title Safety and Modulation of Adaptive Immunity by Iscador Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors (ISCA-CHECK)
Acronym ISCA-CHECK
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors University Hospital, Basel, Switzerland
Indications
Therapies
Age Groups: adult | senior
Covered Countries CHE

Facility Status City State Zip Country Details
Kantosspital Baden AG RECRUITING Baden 5404 Switzerland Details
Universitätsspital Basel RECRUITING Basel 4031 Switzerland Details
Kantonsspital Baselland RECRUITING Liestal 4410 Switzerland Details
Tumor- und Brustzentrum Ostschweiz RECRUITING Saint Gallen 9016 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field